Fig. 1: Antibody titers kinetics. | Bone Marrow Transplantation

Fig. 1: Antibody titers kinetics.

From: SARS-CoV-2-reactive antibody waning, booster effect and breakthrough SARS-CoV-2 infection in hematopoietic stem cell transplant and cell therapy recipients at one year after vaccination

Fig. 1: Antibody titers kinetics.

Antibody titers in BAU/mL at at 3-6 weeks, 3 months and 6 months after complete vaccination and after booster dose a in allo-HSCT, b according to donor type and c in ASCT recipients. a Abbreviations, Q3-med means median interquartil 75%; Med-Q1, median interquartil 25%. * median test p value <0.05. ** median test p value not significant. b Abbreviations, Q3-med means median interquartil 75%; Med-Q1, median interquartil 25%. * median test p value <0.05. ** median test p value not significant. (see Suplementary Table S3 of Fig. 1b). C) Abbreviations, Q3-med means median interquartil 75%; Med-Q1, median interquartil 25%. * median test p value <0.05. ** median test p value not significant. (see Suplementary Table S4 of Fig. 1c).

Back to article page